Recombinant Capital
ReCap's mission is to ensure availability of adequate resources for deserving biotechnology enterprises by providing comprehensive and timely advice and analysis related to the environment for corporate and product development and alliance formation. ReCap's clients include more than 150 biotechnology and pharmaceutical companies, plus several universities, investment banking and venture firms active in the biotechnology area.
|
